The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Resolution of Inflammation in Murine Autoimmune Arthritis Is Disrupted by Cyclooxygenase-2 Inhibition and Restored by Prostaglandin E2-Mediated Lipoxin A4 Production
Open accessAbstract
Acute inflammation follows defined phases of induction, inflammation and resolution, and resolution occurs by an active process that requires cyclooxygenase-2 (COX-2) activity. This study aims to address whether this paradigm extends to recognized model of chronic inflammation. We demonstrated that murine collagen-induced arthritis follows a similar sequential course. Interestingly, COX-2 and its metabolite, the presumably proinflammatory PGE2, are present in the joints during resolution, and blocking COX-2 activity and PGE2 production within this period perpetuated, instead of attenuated, inflammation. Repletion with PGE2 analogs restored homeostasis, and this function is mediated by the proresolving lipoxygenase metabolite, lipoxin A4, a potent stop signal. Thus, the study provided in vivo evidence for a natural, endogenous link between the cyclooxygenase–lipoxygenase pathways and showed that PGE2 serves as a feedback inhibitor essential for limiting chronic inflammation in autoimmune arthritis. These findings may explain the enigma regarding why COX-2 inhibitors are palliative rather than curative in humans, because blocking resolution may mitigate the benefit of preventing induction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Resolution of in flammation: state of the art, definitions and terms
Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-7227rev · Cited by 1,045
Blais, V., Turrin, N. P., & Rivest, S. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03480.x · Cited by 72
Research works printed but not linked: 45
- Gilroy, 1999, Inducible cyclooxygenase may have anti-inflammatory properties., Nat. Med., 5, 698, 10.1038/9550 · DOI · Paper page
- Fukunaga, 2005, Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury., J. Immunol., 174, 5033, 10.4049/jimmunol.174.8.5033 · DOI · Paper page
- Yin, 2007, Prostaglandin I(2) and E(2) mediate the protective effects of cyclooxygenase-2 in a mouse model of immune-mediated liver injury., Hepatology, 45, 159, 10.1002/hep.21493 · DOI
- Reuter, 1996, Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2., J. Clin. Invest., 98, 2076, 10.1172/JCI119013 · DOI · Paper page
- Gilroy, 2004, Inflammatory resolution: new opportunities for drug discovery., Nat. Rev. Drug Discov., 3, 401, 10.1038/nrd1383 · DOI · Paper page
- Schwab, 2007, Resolvin E1 and protectin D activate inflammation-resolution programmes., Nature, 447, 869, 10.1038/nature05877 · DOI · Paper page
- Haworth, 2007, Endogenous lipid mediators in the resolution of airway inflammation., Eur. Respir. J., 30, 980, 10.1183/09031936.00005807 · DOI
- Krönke, 2009, 12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis., J. Immunol., 183, 3383, 10.4049/jimmunol.0900327 · DOI · Paper page
- Lawrence, 2007, Chronic inflammation: a failure of resolution?, Int. J. Exp. Pathol., 88, 85, 10.1111/j.1365-2613.2006.00507.x · DOI · Paper page
- Melnikova, 2005, Future of COX2 inhibitors., Nat. Rev. Drug Discov., 4, 453, 10.1038/nrd1755 · doi:10.1038/nrd1755
- Williams, 2004, Methods in Molecular Medicine Vol. 98 Tumor Necrosis Factor Methods and Protocols, 207
- Terato, 1985, Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule., J. Exp. Med., 162, 637, 10.1084/jem.162.2.637 · DOI
- Adapala, 2008, Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model., Lab. Invest., 88, 1329, 10.1038/labinvest.2008.90 · DOI
- Furuzawa-Carballeda, 2007, Autoimmune inflammation from the Th17 perspective., Autoimmun. Rev., 6, 169, 10.1016/j.autrev.2006.10.002 · DOI · Paper page
- Maini, 1993, TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy., Clin. Exp. Rheumatol., 11, S173
- Blaho, 2008, Arthritis develops but fails to resolve during inhibition of cyclooxygenase 2 in a murine model of Lyme disease., Arthritis Rheum., 58, 1485, 10.1002/art.23371 · DOI
- Kapoor, 2007, Sequential induction of pro- and anti-inflammatory prostaglandins and peroxisome proliferators-activated receptor-gamma during normal wound healing: a time course study., Prostaglandins Leukot. Essent. Fatty Acids, 76, 103, 10.1016/j.plefa.2006.11.006 · DOI
- Rajakariar, 2007, Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2., Proc. Natl. Acad. Sci. USA, 104, 20979, 10.1073/pnas.0707394104 · DOI · Paper page
- Schuligoi, 2005, Sequential induction of prostaglandin E and D synthases in inflammation., Biochem. Biophys. Res. Commun., 335, 684, 10.1016/j.bbrc.2005.07.130 · DOI
- Kojima, 2005, Prostaglandin E synthase in the pathophysiology of arthritis., Fundam. Clin. Pharmacol., 19, 255, 10.1111/j.1472-8206.2005.00316.x · DOI
- Roth, 1989, Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin. Arch., Intern. Med., 149, 775
- Sheibanie, 2007, Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis., Arthritis Rheum., 56, 2608, 10.1002/art.22794 · DOI
- Kojima, 2008, Defective generation of a humoral immune response is associated with a reduced incidence and severity of collagen-induced arthritis in microsomal prostaglandin E synthase-1 null mice., J. Immunol., 180, 8361, 10.4049/jimmunol.180.12.8361 · DOI
- Trebino, 2003, Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase., Proc. Natl. Acad. Sci. USA, 100, 9044, 10.1073/pnas.1332766100 · DOI · Paper page
- Bonnans, 2006, Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury., Am. J. Pathol., 168, 1064, 10.2353/ajpath.2006.051056 · DOI
- Seibert, 1999, COX-2 inhibitors—is there cause for concern?, Nat. Med., 5, 621, 10.1038/9465 · doi:10.1038/9465
- Taylor, 2006, Rheumatoid Arthritis in Practice.
- Reijman, 2005, Is there an association between the use of different types of nonsteroidal antiinflammatory drugs and radiologic progression of osteoarthritis? The Rotterdam Study., Arthritis Rheum., 52, 3137, 10.1002/art.21357 · DOI
- Matuk, 2004, The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel disease., Inflamm. Bowel Dis., 10, 352, 10.1097/00054725-200407000-00005 · DOI
- Takeuchi, 2006, Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease., Clin. Gastroenterol. Hepatol., 4, 196, 10.1016/S1542-3565(05)00980-8 · DOI · Paper page
- Cohen, 2005, Drug exposure and psoriasis vulgaris: case-control and case-crossover studies., Acta Derm. Venereol., 85, 299, 10.1080/00015550510032823 · DOI
- Katayama, 1981, Exacerbation of psoriasis induced by indomethacin., J. Dermatol., 8, 323, 10.1111/j.1346-8138.1981.tb02551.x · doi:10.1111/j.1346-8138.1981.tb02551.x
- Wang, 2006, Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: implication for the adverse effects of cyclooxygenase-2 inhibitors., Clin. Pharmacol. Ther., 79, 303, 10.1016/j.clpt.2005.12.306 · doi:10.1016/j.clpt.2005.12.306
- Ben-Baruch, 2006, Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators., Semin. Cancer Biol., 16, 38, 10.1016/j.semcancer.2005.07.006 · DOI · Paper page
- Baratelli, 2005, Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells., J. Immunol., 175, 1483, 10.4049/jimmunol.175.3.1483 · DOI · Paper page
- Gomez, 2005, Resolution of inflammation: prostaglandin E2 dissociates nuclear trafficking of individual NF-kappaB subunits (p65, p50) in stimulated rheumatoid synovial fibroblasts., J. Immunol., 175, 6924, 10.4049/jimmunol.175.10.6924 · DOI
- Shibata, 2007, Immunologic response enhances atherosclerosis-type 1 helper T cell (Th1)-to-type 2 helper T cell (Th2) shift and calcified atherosclerosis in Bacillus Calmette-Guerin (BCG)-treated apolipoprotein E-knockout (apo E-/-) mice., Transl. Res., 149, 62, 10.1016/j.trsl.2006.08.008 · DOI
- Sugimoto, 2007, Prostaglandin E receptors., J. Biol. Chem., 282, 11613, 10.1074/jbc.R600038200 · DOI · Paper page
- Honda, 2009, Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity., J. Allergy Clin. Immunol., 124, 809, 10.1016/j.jaci.2009.04.029 · DOI
- Ogawa, 2009, The mechanism of anti-inflammatory effects of prostaglandin E2 receptor 4 activation in murine cardiac transplantation., Transplantation, 87, 1645, 10.1097/TP.0b013e3181a5c84c · doi:10.1097/tp.0b013e3181a5c84c
- Prickett, 1984, Dietary fish oil augments the induction of arthritis in rats immunized with type II collagen., J. Immunol., 132, 725, 10.4049/jimmunol.132.2.725 · DOI
- Leslie, 1985, Dietary fish oil modulates macrophage fatty acids and decreases arthritis susceptibility in mice., J. Exp. Med., 162, 1336, 10.1084/jem.162.4.1336 · DOI · Paper page
- Clària, 1995, Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions., Proc. Natl. Acad. Sci. USA, 92, 9475, 10.1073/pnas.92.21.9475 · DOI · Paper page
- Blaho, 2009, Lipidomic analysis of dynamic eicosanoid responses during the induction and resolution of Lyme arthritis., J. Biol. Chem., 284, 21599, 10.1074/jbc.M109.003822 · DOI
- Couzin, 2004, Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors., Science, 306, 384, 10.1126/science.306.5695.384 · DOI
Cited by
Pro-resolving lipid mediators are leads for resolution physiology
Serhan, C. N. (2014) · Nature · doi:10.1038/nature13479 · Cited by 3,041
Eicosanoid storm in infection and inflammation
Dennis, E. A., & Norris, P. C. (2015) · Nature Reviews Immunology · doi:10.1038/nri3859 · Cited by 1,517
Resolution of inflammation: a new therapeutic frontier
Fullerton, J. N., & Gilroy, D. W. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.39 · Cited by 937
Specialized pro-resolving mediators: endogenous regulators of infection and inflammation
Basil, M. C., & Levy, B. D. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.4 · Cited by 791
Resolution of Inflammation: What Controls Its Onset?
Sugimoto, M. A., Sousa, L. P., Pinho, V., Perretti, M., & Teixeira, M. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00160 · Cited by 638
Metadata
- Authors
- Chan, M. M.-Y., & Moore, A. R.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-06-01
- Volume
- 184
- Issue
- 11
- Pages
- 6418-6426
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2159210732
- Cited by
- 183
- References
- 3
- FWCI
- 8.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.